Tomoki Sugiyama

A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy

Yuki Murase, Tomohiro Asai, Yasufumi Katanasaka et al. · Cancer Letters · 2009 · 54 citations

Nanomedicine, Molecular Pharmacology, Drug Targeting +11

A novel Nrf2 activator, RS9, attenuates secondary brain injury after intracerebral hemorrhage in sub-acute phase

Tomoki Sugiyama, Takahiko Imai, Shinsuke Nakamura et al. · Brain Research · 2018 · 34 citations

Secondary Brain Injury, Cerebral Vascular Regulation, Stroke +14

Enhanced Active Targeting via Cooperative Binding of Ligands on Liposomes to Target Receptors

Tomoki Sugiyama, Tomohiro Asai, Yuki Murase Nedachi et al. · PLoS ONE · 2013 · 31 citations · Full text

Proteinlipid Interaction, Drug Target, Nanotherapeutics +28

Deferasirox, a trivalent iron chelator, ameliorates neuronal damage in hemorrhagic stroke models

Takahiko Imai, Shohei Tsuji, Hirohumi Matsubara et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2020 · 29 citations

Neuronal Damage, Social Sciences, Cerebral Vascular Regulation +16

Levetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury

Takahiko Imai, Tomoki Sugiyama, Sena Iwata et al. · Neuroscience · 2020 · 13 citations

Intracranial Hemorrhage Injury, Stroke, Antiepileptic Drug +13